Regenxbio (RGNX) Change in Receivables (2014 - 2025)

Regenxbio's Change in Receivables history runs 12 years deep, the most recent figure standing at $561000.0 for Q4 2025.

• In Q4 2025, Change in Receivables rose 106.9% year-over-year to $561000.0; the TTM figure through Dec 2025 stood at $7.7 million (up 178.92% YoY), while the FY2025 annual figure was $7.7 million, up 178.92% from the prior year.
• Change in Receivables was $561000.0 for Q4 2025 at Regenxbio, down from $6.3 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $10.7 million in Q2 2022 to a low of -$22.0 million in Q4 2021.
• Historically, Change in Receivables has averaged -$1.2 million across 5 years, with a median of -$505500.0 in 2025.
• The sharpest annual moves came in 2022 and 2025: Change in Receivables tumbled 251.61% in 2022, then surged 788.73% in 2025.
• A 5-year view of Change in Receivables shows it stood at -$22.0 million in 2021, then soared by 77.99% to -$4.8 million in 2022, then soared by 30.45% to -$3.4 million in 2023, then slumped by 141.41% to -$8.1 million in 2024, then soared by 106.9% to $561000.0 in 2025.
• The last three Change in Receivables figures came in at $561000.0 (Q4 2025), $6.3 million (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.